Bacterial-polivalent-vaccine(Inmunotek)

N/A

Report date: 2025/10/03 20:00:59

Base Information

Drug NameBacterial-polivalent-vaccine(Inmunotek)

Drug Alias NameBacmuneBACTEK-RBactekMV-130Bactek-O +[6]

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Disease, Chronic ObstructiveBronchial Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMexicoSpainDominican Republic

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesInmunotek Sl

China Registration ClassN/A

Develop Information

Active CompaniesInmunotek Sl

Inactive CompaniesN/A

Active IndicationsPulmonary Disease, Chronic Obstructive

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Bronchial Diseases

Other Information

ATC CodeN/A